| | |||||
| disease | |||||
| 网页 | |||||
| What the First TK2d Therapy Can Teach Us About Drug Development for Ultrarare Diseases In November 2025, doxecitine and doxribtimine (Kygevvi®) became the first therapy approved by the US Food and Drug Administration (FDA) for ...
| |||||
| Parkinson's disease Diagnosis and prognosis: A Systematic Review of Machine Learning ... Parkinson's disease (PD) is a progressive and complex neurodegenerative disorder associated with ageing, affecting both motor and cognitive ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment